Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) last traded at $3.96, down 7.04% on the session. The quote above updates while this page is open; the figures below are drawn from Anbio Biotechnology Class A Ordinary Shares’s own filings and are restated only when a new one is published.
Anbio Biotechnology Class A Ordinary Shares trades on NASDAQ under the ticker NNNN. Its market capitalisation is $172.94 million.
Valuation measures for Anbio Biotechnology Class A Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $172.94M |
|---|---|
| Enterprise value | $165.26M |
| P/E ratio | 26.94 |
| Price / sales | 20.00 |
| Price / book | 5.74 |
| Beta |
| 0.30 |
Trailing-twelve-month figures tagged in Anbio Biotechnology Class A Ordinary Shares's XBRL filings with the SEC.
| Revenue (TTM) | $8.65M |
|---|---|
| Net income (TTM) | $6.40M |
| EPS (TTM) | $0.147 |
| Gross margin | 87.24% |
| Operating margin | 66.70% |
| Return on equity | 21.24% |
| Cash | $7.77M |
Range and volume for NNNN over the past 52 weeks.
| 52-week high | $44.73 |
|---|---|
| 52-week low | $3.88 |
| Volume | 6.1K |
| Average volume | 143.1K |
| Previous close | $4.26 |
Invest a chosen dollar amount in Anbio Biotechnology Class A Ordinary Shares with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell NNNN.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.